US Patent Issued to INNOBM PHARMACEUTICALS on Nov. 3 for "Self-sustained release immune adjuvant suspension, preparation method therefor, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,034, issued on Nov. 3, was assigned to INNOBM PHARMACEUTICALS Co. LTD. (Suzhou, China).

"Self-sustained release immune adjuvant suspension, preparation method therefor, and use thereof" was invented by Zhuang Liu (Suzhou, China), Huiquan Tao (Suzhou, China), Zhongqing Deng (Suzhou, China), Yuchen Wu (Suzhou, China), Shang Bai (Suzhou, China) and Xuanfang Zhou (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present application relates to a self-sustained release immune adjuvant suspension comprising microparticles composed of a lipid soluble immune adjuvant and a surfactant, the balance being a dispersant, wherein the lipid soluble i...